Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Fever × dabrafenib × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 6 Neoplasms 2 Skin Neoplasms 1 Sarcoma 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Neoplasm Metastasis 1 Fever 1 Differentiated Thyroid Cancer (DTC) 1 Ameloblastoma 1

Interventions

Vancomycin 2 Cefepime 2 trametinib 1 pegfilgrastim 1 liposomal amphotericin B 1 dabrafenib 1 ceftobiprole medocaril 1 Tazobactam 1 Piperacillin, Tazobactam Drug Combination 1 Piperacillin 1 Levofloxacin 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Filgrastim 1 Ciprofloxacin 1 Bevacizumab 1 Anti-Bacterial Agents 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03551626 2025-04-29

COMBI-APlus

Novartis

Phase 3 Completed

552 enrolled 12 charts

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡